SCHEMBL2002170

SCHEMBL2002170

CC(O)CC(C)(O)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butanol SCHEMBL28361508 0.72 TSHR (0.53)
SCHEMBL1110692 0.70
SCHEMBL19834916 0.70 CYP1A2 (0.37)
Hexylene Glycol SCHEMBL335683 0.69
Hexylene Glycol SCHEMBL123432 0.69
SCHEMBL28964362 0.69
Hexylene Glycol SCHEMBL6869929 0.69 MAPK1 (0.39)
SCHEMBL16074731 0.69 MAPK1 (0.39)
Hexylene Glycol SCHEMBL19379 0.69
Hexylene Glycol SCHEMBL3391421 0.69 MAPK1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960516-B2 Solid forms of anti-EGFR antibodies MERCK PATENT GMBH (DE) 2011-06-14 US disclosed
EP-1974723-A2 Secure forms of anti-EGFR antibodies Merck Patent GmbH (DE) 2008-10-01 EP disclosed
US-20070122411-A1 Solid forms of anti-egfr antibodies MERCK PATENT GMBH (DE) 2007-05-31 US disclosed
EP-1686961-A1 SOLID FORMS OF ANTI-EGFR-ANTIBODIES MERCK PATENT GmbH (DE) 2006-08-09 EP disclosed
WO-2005051355-A1 SOLID FORMS OF ANTI-EGFR-ANTIBODIES MERCK PATENT GMBH (DE) 2005-06-09 WO disclosed